AngioDynamics (NASDAQ:ANGO – Get Free Report) issued an update on its second quarter earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of ($0.05) for the period, compared to the consensus estimate of ($0.08). The company issued revenue guidance of $79.1 million, compared to the consensus revenue estimate of $81.95 million. […]